in this issue
People & Business :: Companies
Syngenta Invests in U.S. Biotech Firm
2:53 AM MDT | October 27, 2009 | Deepti Ramesh
Syngenta says its newly-established Syngenta Ventures corporate venture capital subsidiary, has made an equity investment in Metabolon (Durham, NC), a privately-held biotechnology company focused on the use of metabolomics in research and diagnostics. This is the first direct investment by Syngenta Ventures. Financial details of the equity investment in Metabolon were not disclosed. Metabolomics provides mechanistic insight and biochemical markers for complex biological processes, Syngenta says. This technology aims to accelerate the development of plants with...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee